Ratovohery D, Assous M V, Gilly L, Brun T, Nevot P, Paul G
Laboratoire de Bactériologie, Faculté de Médecine Cochin Port-Royal, Paris.
Ann Med Interne (Paris). 1994;145(4):234-7.
The antibacterial effect of tobramycin-netilmicin combination on multiresistant strains of staphylococcus was performed to determine the signification of synergy images on diffusion plates. Meticillin and gentamicin resistant strains of S. epidermidis (2 strains) and S. aureus (1 strain) were examined and showed an index of combined effect < 0.05 demonstrating synergy. These values were obtained with aminoglycoside concentrations < or = 4 mg/l, levels which can be considered as pharmacologically acceptable. This synergic action can be explained by specific inhibition of the resistance enzyme in the strains, possibly in combination with a cooperative effect on the classical targets of aminoglycosides. This type of combination using tobramycin and netilmicin could define a new use of aminoglycosides based on the conception of combining antibiotic enzyme inhibition.
进行了妥布霉素-奈替米星联合用药对耐多药葡萄球菌菌株的抗菌作用研究,以确定扩散平板上协同图像的意义。检测了对甲氧西林和庆大霉素耐药的表皮葡萄球菌(2株)和金黄色葡萄球菌(1株),联合效应指数<0.05,表明有协同作用。这些数值是在氨基糖苷类浓度≤4mg/L时获得的,该浓度可被视为药理学上可接受的水平。这种协同作用可以通过对菌株中耐药酶的特异性抑制来解释,可能还与对氨基糖苷类经典靶点的协同作用有关。基于联合抗生素酶抑制的概念,这种使用妥布霉素和奈替米星的联合用药方式可能会定义氨基糖苷类药物的一种新用途。